Literature DB >> 435055

The Hartmann procedure for complications of diverticulitis.

G C Nunes, A H Robnett, R M Kremer, R E Ahlquist.   

Abstract

A Hartmann procedure was performed on 25 patients with complications of acute diverticulitis. Of the 20 patients in whom both stages were completed, 14 had a smooth course. Total hospitalization for both stages averaged 23 days. Mortality was 8%. The initial resection usually is not difficult. Subsequent reanastomosis is facilitated by an interval of at least three months between stages. The advantages of the Hartmann procedure are as follows: (1) The diseased bowel is removed at the first stage. (2) The risk of primary anastomosis is avoided. (3) Hospitalization and overall time of treatment are reduced. (4) Mortality is relatively low. The Hartmann procedure should be considered for a broader selection of patients with complications of acute diverticulitis.

Entities:  

Mesh:

Year:  1979        PMID: 435055     DOI: 10.1001/archsurg.1979.01370280079011

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

1.  Hartmann procedure: place in surgery and what after?

Authors:  K Bielecki; P Kamiński
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

Review 2.  Laparoscopic Lavage in the Management of Hinchey III/IV Diverticulitis.

Authors:  Maria X Kiely; Mengdi Yao; Lilian Chen
Journal:  Clin Colon Rectal Surg       Date:  2021-02-24

3.  Hartmann's procedure: an appraisal.

Authors:  R J Whiston; N C Armitage; D Wilcox; J D Hardcastle
Journal:  J R Soc Med       Date:  1993-04       Impact factor: 18.000

Review 4.  A historical review of surgery for peritonitis secondary to acute colonic diverticulitis: from Lockhart-Mummery to evidence-based medicine.

Authors:  Roberto Cirocchi; Sorena Afshar; Salomone Di Saverio; Georgi Popivanov; Angelo De Sol; Francesca Gubbiotti; Gregorio Tugnoli; Massimo Sartelli; Fausto Catena; David Cavaliere; Renata Taboła; Abe Fingerhut; Gian Andrea Binda
Journal:  World J Emerg Surg       Date:  2017-03-09       Impact factor: 5.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.